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Evaluation of regional mywardiat blood Aow with radionu- 
elide techniques plays an important mk in the diagnosis and 
management of coronary artery disease. The presence of a 
segmental defect on stress images of myocardial blood Row 
depends on a differential flow reserve between nonal 
myocaniium and myocardium supplied by a critically 
slenosed coronary tiery. Maximal exercise usually serves 
as the stimulus for myocardial hyperemia. In patients unable 
to exercise. pharmacologic vasodilation offers an altema- 
tive. The agent most commonly used for this purpose is 
intravenous dipyridamok. 
Dipyridamok thallium-201 xintigraphy has been shown 
to have a sensitivity and specilkity cemparabk to those of 
exercise scimigraphy for the detection of coronary awry 
disease and it provides important propaor+ic information i  
patients with such disease (I). The mechanism of action of 
dipyridamole is indirect and appears 10 be related to an 
increased interstitial concentration of adamsine, a potent 
coronary vasodilatw. Dipyridamok inhibits the cellular R- 
uptake of adamsine and metabolism by adenosine deami- 
nase. Other modes ofactian of dipyridannuie iasiuds iribibi- 
tion of phosphodksterase and an increase in prostacyclin 
synthesis (2.3). 
intravenous aienorine has recently become available as 
an alternative agent for pharmacologic stress imaging. Aden- 
osine activates specific receptors at tk membranes of the 
smooth mucks of the coronary circuktioo (4) that initiate 
production of cyclic adenosine monophosphate, smooth 
muscle r&nation and a decrease in slow inward calcium 
current. Intravenous adenasine has a rapid onset of action 
and a biologic II&life of <2 s (5). These properties make 
intravenous adenosine an attractive agent for use with myo- 
cardial blood Row imaging. 
Although both dipyridamole and adenosine have been 
reported to be similarly effective in detecting coronary artery 
disdase (6), no infommtion exists as to whether the magni- 
tude of hyperemia achieved with the two agents is cornpa- 
rable. The purpose of this studv was to suantifv in normal 
subjects the in&ease in myocardial blood f&v iniesponse to 
intravenous adenosine and ipyridamole by using dynamic 
positron emission tomography and intravenous nitrogen-13 
(N-13) ammonia as a tracer of myocardial perfusion. 
Methods 
Study group. Twenty normal male volunteers with an 
average age of 34.5 + 15.8 years (range i8 to 84) were 
?tndird (Table 1). After the rationale, investigative nature 
and risks of the stady were explained, each subject signed an 
informed consent form approved by the Human Subject 
Protection Committee at the University of California, Los 
Angeles. Beverages containing caffeine were withheld for al 
least 12 h before the study. None of the men had a history of 
cardiovascular disease, and each had normal findi& on 
physical examination and a 12.lead electrocardiogram (ECG) 
at rest and nomxd exercise tolerance. In addition, men >Y 
Appropriate positioning uf the subject’s heart within the 
actual field of view of the tomograph was first confirmed on 
a 4.min rectilinear transmission scan. Twenty-minute trans- 
axial transmission images were then acqr;ired and used for 
subsequent correction for photon a!tenuation. An intwe- 
nous bolus of I2 mCi of N-13 ammonia was administered 
over 30 s while acquisition of serial tmnsaxird emission 
years of age underwent a symptom-limited submaximal images for 23 min was started. Forty-five minotes later, after 
treadmill exercise stress test to rule out silent &hernia. physical decay of the N-13 activity to nearly undetectable 
None developed chest pain or BCG evidence of myocardial 
ischemia during the exercise stress test. Therefore all seb- 
jects had ~7% probability of silent coronary artery disease 
by Bayesian analysis (7). 
Study protocol. All subjects were studied with dynamic 
positron emission tomography and intravenous N-13 ammo- 
nia at rest, during intravenous adenosine infusion and after 
intravenous dipyiidamole infusion. Intravenous adenosine 
(Adeww) ?ias supplied by Medco Research, Inc. Intra- 
venous dipyridamol; -(Persantine) was supplied by Boehr- 
inger ingelheim. 
Nitrogen-I3 ammonia was produced at the University of 
California. Los Angeles Medical Cyclotron as described 
previously (8). lmt&g was performed with a whole body 
wsitron emission ton;oeraoh (model 93118. CTl/Siemans 
&mna.sonics), which si~uliane&ly acquir& I5 transverse 
slices spaced 6.75 mre apart and cows a IO&m axial field 
of view (9). 
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levels, adenosine was administered inrnvenously at a rate of 
N-13 activity, dipyridamole was infused intravenously at a 
I40 @kg body weight per min for 6 min. Three minutes after 
the stafl cc zdeno&e iat%sicr.. N-t3 amxiz v:ss z&. 
rate of 0.56 mgikg over 4 min. Four minutes after the end of 
administered and a second set of senal transaxial imageswas 
acauired. After another 45 mitt and after dissioation of the 
ghkmacologic effects ofadenosine and physicai decay of the 
estimates 2nd from correction factors to compensa:e for the 
measured tissue activity concentrations for partial volume 
et?ects. A small blood pool region of interest (area 5 to 
79 mm’) corresponding to the left ventricutar cavity was 
defined r?isne&y 0” P.-k “^A^1 :.“I .= “” .-. =..,_. . . .._ _. ..d the tierial input 
function was generated. 
Myocardial and blood pwl time-activity curves were 
corrected for physical decay to the time of in&ion. Mvo- 
cardial blood Row was c&&ted for each my&ardiaI se& 
by using the :st 120 s of the corrected mvocardial time- 
acti-dity curves and the arterial input function and a previ- 
ously validated two-compartment tracer kinetic model 
@.I 11. A mean myocardii blood Row value was obtained for 
each study by averaging the values of the six myocardial 
sectors. The co&icient of variation for each study WIS 
determined by dividing the standard deviations of the secto- 
rid Row values by the average Row value. 
used io delem&e statistically signiticanl differences be- 
Wee” gmupr. The Student , test for paired data and the 
S&Xi&at aatyrts N Chc .&a+. Statistics were c&eked 
-il’n _ Lomaz:idy a Clab!: ~rsonal computer software 
pmgran 6tatview 512+, Abacus Concepts, Inc.). V&es 
are expressed as mean value + SD. Two-way analysis of 
variance with repeated measures and the SchetE F test were 
tbe infusion, athird dose oiN-13 ammonia was administered 
_ 
exposure resulting from the cumulative dose of36 mCi of 
with acquisition of serial transaxial images. 
N-13 ammonia during the procedure was 0.036 red tl0). 
Subject movement within the tomograph was minimized 
by wappiog a Velcro strap across the chest. Heart rate, 
Images were acquired serially to determine noninvasively 
blood pressure and a IZlead ECG were monitored regularly 
duriwz the orocedure. The estimated total b&v radiation 
the arterial tracer inout function and the mvocardiat tissue 
chi-square lesl were used lo compare values between two 
Hcmodylmmie 
groups. A probability value < 0.05 was considered gnifi- 
-maus. Hemodynamic variables at 
cant. 
baseline. during intravenous adenosine infusion and after 
intravenous dipyridamole infusion are shown in Table I. The 
heart rate increased sifmiticaotlv during adenosioc infusion 
ReSUit.3 
response. The im& acquisition sequenceswere I2 frames 
of IO s each. followed by 2 frames of 30 s each, 5 frames of 
6OseachaodIfmmeof9Xts. 
image analysis nod catcutation of mywrdtal blood Bow. 
Tbe serially acquired transaxial images were transferred to a 
Macintosh II personal computer and reoriented into left 
ventricular short-axis views using a computer software pro- 
gram described previously (I I). A midventricular shot%axis 
image was used for quantitative analvsis. The left ventricular 
my&rdium on thii short-axis cro& section was outlined 
with a semiautomatic coomuter oroamm III) and divided 
into six sectors (Fig. I). M&cardial&xtors ranged in area 
from 119 to 173 nm’. The outline and sect&d regions of 
interest were copied to all the serial images and &age 
tissue activity concentrations for each region in countsfmm* 
were calculated. 
Estimates of secloriat wall thicknesses were obtained by 
a model-based and previously validated profile-fitting algo- 
rithm that was awlied to radial mvocardial activitv ~mfilcs 
with the use oinonlinear reg&ion algorirhm; il2.13). 
Regional recovery coe5icients for each of the six seclori~l 
regions of io:erest were then derived from the wall thickness 
and was similar for the‘adenosi& and &ridamole studies. 
Although systolic pressures initially decreased after dipyrid- 
amole and aaenosine infusions, they returned lo control 
values at the time of tracer inject&. Thus systolic and 
diastolic btwd pressure; did not differ si&icanlty between 
the three studies. No subject repmied a major adverse 
reaction (chest pain, heart block or acute asthmatic attack) 
to either of the two drugs (Table 1). Miwr adverse events 
cccurred io I9 subjects during &twine infusion but in only 
9 subjects after dipyridamole infusion &hi-square = 11.92, 
D < 0.001). 
Hcmoga&ydmyaeardlatbIoodhatbnstlimawJ 
during phmwceW& va&itatton. Mywardial blwd Bow at 
baseline was homogeneous throughout the left ventricular 
myocardium and remained homogeneous during both hy- 
perernie studies in all suhiects. None of the images revealed 
&egmental defects of tra&r uptake on visuzl inspection at 
baseline or new hyperemia-induced defects on the adenaaine 
or dipyridanmle images (Fig. 2). Tbc co4Itcienls of variation 
oi myocardial blood flow for each subject al rest and during 
intravenous adenosine and after inlravenous dipyridamole 
administration are listed in Table 2. There were no signiti- 
Adenosine 
contiguous short-axis images of myo- 
cardial N.13 ammonia uptake at base- 
cant di5erences between the mean coetlicient of variation of baseline ranged from 0.6 to 1.4 mUmin ixr g (average I .I f; 
perfusion at rest (0.17 + 0.05) or durin.e intravenous adeno- 0.21. During~intravenous adenosine, m&rdial blood Row 
sine (0.21 -C 0.08) or after intravenous dipyridamole (0.19 f ranged from 2.5 to 5.8 mllmin per g (average 4.4 + 0.9). With 
0.09). intravenous dipyridamole, myocardial blood flow ranged 
Myocardial blood Rows at baseline and during pharmsco- from 1.5 to 6.2 mllmin per g (average 4.3 e 1.3). Thus mean 
logii vawdilalion. Mean values of myocardial blood Row at myocardial blood Row increased significantly with intrave- 
baseline and during inlravenvr adenaini &II,: intravenous nous adenosine (p < O.ooOl) and with dipyridamole (p < 
dipyridamole administration are given for each subject in O.ooOl) but did not di5er significantly between the adenosine 
Table 2 and illustrated in Figure 3. Myocardial blood flow at and the dipyridamole studies (p = NS). 
Table 2. Mvocardial Blood Flow at Baseline and Durina Pharmacoloeic Vasadilafion 
2 
4 
Bas~lne Adenorins Dip”fidamOle 
Ftgure3. lndwidual values ofaverage myocardmt blood Row tMBFl 
at baseline, durinr adenosine infusion and after diovridamolc infw 
rion. Note the h&dual variability in the rap&; to phammca 
lo@ vaxditation, although the mean values for the group of 20 
volunteers are similar for bath hyperemic condihons 
Myocardial perfusion reserve. defined as the rario of 
hyperemic to baseline blood Row. ranged from 2.0 to 8.4 
with adenosine and averaged 4.3 + 1.6: for dipyridamole. it 
ranged from 1.5 to 5.8 and averaged 4.0 r I.3 (p = NS vs. 
adenosine). 
There were substantial variations in the individual re- 
sponses to both agents. In four subjects, myocardial blood 
flow during intravenous adenosine administration was more 
than I mUmin per g higher than after intravenous dipyrida- 
mole administration. Conversely, in five subjects, mean 
myocardial blood Rows after intravenous dipyridamole were 
>I mllmin per g higher than during intravenous adenosine. 
In the remaining subjects, blood flow differed by 41 mlJmin 
per g between the adettosine and the dipyridamole studies. 
The relation between the heart rate-systolic blwd pres- 
sure product and myocardird perfusion is shown in Figure 4. 
There is M overall trend between higher rate-pressure 
products and mean myocardial blood ROWE. However, the 
Flgure 4. Relation between mean myocardial blood Rows (MBFI 
and the rate-pressure product. 
conriderable scatter about he regression line cuggests the 
~mponance of other factors. 
Discussion 
Standard doses and intravenous infusion rates of adeno- 
zinc (140 &kg per min) and dipyridamote (0.X mg’kg over 
4 mini mcreawd myocardial blood flow sisn:t%antlv above 
levels at rest. The increase was homogene& throughout he 
left ventricular myocardium. as evidenced by visual mspec- 
tion of the contiguous transaxird images and the wr9aot 
coefficient of variations. However, there were substantial 
~arinicns in the :espaw to the two agents in inoividual 
subjects. On average, both adenosine and dipyridamole 
infusions achieved similar levels of myocardial hyperemia. 
Methodok@c considwtiotts. Myocardial blwd Row was 
quantified by high temporal resolution positron emission 
tomography with intravence; N-13 ammonia and a tracer 
kinetic model that has been validated in animal experiments 
(11.14)and uredin humans(O. Only the initial 120s ofimage 
data was used for model fitting because this procedure 
minimizes contamination of the arterial input fanction by 
N-&labeled met&&es of N-13 ammo&. In hum&, 
N-l? ammonia metabolites have been reported to constitute 
ooly 6% of the toal N-13 blood activity at 2 min (IS). 
Quantification of myocardial blood flow further relied on 
reoriented short-axis cross sections of the left ventricular 
myocardium. a factor that permitted accurate estimates of 
regional myocardial wall thickness. which is important for 
accurate correction for regional partial volume effects (I I). 
Such corrections are problematic on bansaxial images be- 
cause the anterobasal and inferior egions of the left ventri~- 
ular myocardium traverse the image planes in an oblique or 
even tangential fashion. This panern precludes adequate 
measurements of regional tracer activity concentrations as 
we!! 3s appropriate corrections for partial volume effect in 
these regions. Although the baseline and hyperzmic esti- 
mates of blood flow in this study are comparable to those 
obtained previously with N-13 ammonia from transaxial 
tomographic images (16). these mea~orements were confined 
largely to mid-ventricular image slices that traverse the 
image plane in a more perpendicular fashion. 
Randomization of the order in which the vasodilator 
agents were administered was not possible because the 
longer half-lie of intravenous dipyridamole (3) would have 
interfered with the action of adenosine. Although the study 
group included older subjects, care was raken to role out the 
presence of coronray artery disease. Its absence was con- 
armed by tbe homogeneous distribution of blood Row at rest 
as well as during both hyperemic studies which, in view of 
the previously reported higb sensitivities and specificities of 
positron emission tomography for the detection of coronary 
artery disease (17,18), argued againsr the presence of this 
disease. 
Compmiwn with invasive measwements. In this group of 
Hem Rme-syaomlic P1855”m Pmd”cl healthy men, intravenous adenosine resulted in an average 
hyperemia to bare!ine blood flow ratio of 4.3 + I .6. although 
individual responses varied. For example, the Row ratio was 
il SD below the mean value in 3 (15%) of the 20 subjects. 
The results are similar to changes in coronary Row velocities 
determined with intercoronary Doppler catheters before and 
affer intrevenou~ adcnosine administration (19). Flow veloc- 
ities in normal coronary arteries increased oo average by 
>4W%. They increased maximally in 84% of the coronary 
arteries. In comoarison. intravenous diwridamole in the 
current study re&ted in a hyperemia to &line blood Row 
ratio of 4.0 + 1.3. Individual responses varied, and flow 
ratios ranged from 1.5 to 5.8 and’were <I SD below the 
mean in three (15%) of the volunteers. Studies with intra- 
coronary Doppler catbcters (6) revealed a range of coronary 
Row responses to intravenous dipyridamole from 1.9 to 5.4 
(mean 3.7 t 1.2). A Row reserve >3.0 war seen in only 
66.7% of the subjects studied (6). 
The variable response of myocz:dial blood Row to either 
intravenous adenosine ordipyridamole is therefore similar to 
that observed with intmcoronaly Doppler probes. The rela- 
tively small number of subjects with suboptimal responses 
precludes elucidation of bemodynamic criteria that would 
distinguish between suboptimal and optimal Row responses. 
Although intravenous infusion by both adenosine and dipyr- 
idamole invariably affected the heart rete, the agents did 
exert a pharoncologic effect. Further, the rate-pressure 
product correlated significantly with mvocardial blood Rows. 
Although we are nit implying a direct relation between 
hypremic blood flows and hean rate or aortic pressare, the 
correlation might reflect a primary response of the systemic 
circulation to the wsodi!ator. Although this co!?!ation 
might serve as an index of the pharmacologic effect ar the 
coronary circulation, its value appears limited because ofthe 
relatively large data scatter about the regression line. Fur- 
iiwmore. the mean hyperemia to baseline flow ratios were 
similar for intravenous adenosine and for intravenous dipyr- 
idamole. Neverlhelers, the responses to the two ag& 
differed considerably in some subjects. 
Possible causes of variable Row responses. Several reasons 
might account for the variations in Row response. Intrave- 
nous adenosine has been shown in animals and humans to be 
a potent. direct-actino coronarv vasodilator (4-6). In coo- 
t&, the effect of dipyridamdle is indirect because it is 
mediated in port through the inhibition of uptake and metab- 
olism of adenosine (3). However. five of our subjects had 
higher myocardial blood Rows in response to dipyridamale 
than to adenosine. The pharmacologic effects of adenosine in 
these subjects are evidenced by the associated hemody- 
namic changes as well as by the high incidence of minor 
adverse reactions to adenosine. The differential effects of 
intravenous adenosine and intravenous dipyridamole in 
these subjects may be related to differences in metabolism of 
the two compounds. Adenosine has a very short (c2.0 s) 
half-life in viva Exogenous adenosine is primarily metabo- 
lized through incorporation into the cellular adenine nucle- 
o:ide pool, a process that takes place mainly at the vascular 
endothelium (5). Wilson et al. (19) demonstrated that a 
fraction oiadenosine was metabolized during its transit from 
the peripheral venous infusion site to the myocardium. It is 
possible that in some persons, exogenous adenosine is 
rapidly metabolized by peripheral venow vascular endothe- 
lium. Concentrations of adcnosine in the coronary circula- 
tion might therefore be inadequate to produce maximal 
coronary vasodilation. In contrast, dipyridamole is bound to 
an acidic alpha,-glycoprotein in plasma and metabolized 
mainly through conjugation to glucuronide in the liver (3). 
An enterohepatic circulation of dipyridamole has been dem- 
onstrated in humans. The multiple .teps of dipyridamole 
metabolism imply that after intravenous infusion, dipyrida- 
mole plasma concentrations may very widely among individ- 
ual subjects. It is conceivable that dipyridamole concentre- 
tions in some persons may achieve levels that result in 
supranormal elevations of endogenous adenosine. Either 
one or both of these mechanisms may result in myocardial 
blood flows that are higher with intravenous dipyridamole 
than with intravenous adenosine. Additional factors might 
be related to age (20). Although the age of our subjects 
ranged from I8 to 84 years, the study group was too small to 
reveal any significant age-related trend, even though the 
oldest participant, 84 years of age, hod a somewhat blunted 
hyperemic response. 
Conclusions. Our results suggest that intravenous adeno- 
sine and intravenous dipyridamole are equally effective in 
inducing myocardial hyperemia. 
In cootrast to previously reported findings with invasive 
approaches such as introcoronary Doppler flow probes 
(6,19.21), the curreot study demonstrates that rest and 
byperemic myocardial blood flow eon be quantified nonin- 
vasively with positron emission tomography, N-13 ammonia 
and an appropriate tracer kinetic model. Substantial vatia- 
tions in individual responses to these two agents were noted 
and suboptimal responses could not be accurately predicted 
from the hemodynatoic e&m ~1 ;hc d&r,t. Xws~h:!rrc, 
the average magnitude of hyperemia and the proportion of 
subjects with a maximal respottx induced by these two 
agents were found to be similar. 
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